Tilray CEO on first earnings file and rising cannabis substitute

Tilray CEO on first earnings file and rising cannabis substitute

Tilray CEO Brendan Kennedy discusses his firm’s enhance alongside the expansion of the clinical pot substitute as a total.

Read more »